Article

Exhaustive circulating tumor DNA sequencing reveals the genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive detection of minimal residual disease

2021-03-24

Abstract excerpt

Individualizing treatment is key to improve outcome and reduce long-term side-effects in any cancer. In Hodgkin lymphoma (HL), individualization of treatment is hindered by a lack of genomic characterization and technology for sensitive, molecular response assessment. Sequencing of cell-free (cf)DNA is a powerful strategy to understand an individual cancer genome and can be used to develop assays for extremely sen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 78d9b844-ecb6-5cb6-80e3-7d768b7b64bc
DOI: 10.1101/2021.03.16.21253679

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exhaustive circulating tumor DNA sequencing reveals the genomic landscape of Hodgkin lymphoma and facilitates ultrasensitive detection of minimal residual diseaseDOI 10.1101/2021.03.16.21253679Read

In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin’s lymphoma and facilitates ultrasensitive residual disease detectionSemantic proximity Read

Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.Semantic proximity Read

Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.Semantic proximity Read

Liquid biopsy in lymphoma: Molecular methods and clinical applications.Semantic proximity Read

Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?Semantic proximity Read

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNASemantic proximity Read

Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA.Semantic proximity Read

Circulating Tumor DNA in Lymphoma.Semantic proximity Read

Molecular sleuthing: unmasking hidden lymphomas through plasma DNA sequencing.Semantic proximity Read

Assessing the Concordance of Genomic Alterations between Circulating-Free DNA and Tumour Tissue in Cancer PatientsSemantic proximity Read

Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma.Semantic proximity Read

Somatic mutations of cell-free circulating DNA detected by targeted next-generation sequencing and digital droplet PCR in classical Hodgkin lymphomaSemantic proximity Read